Cargando…

Aberrant miRNAs expressed in HER-2 negative breast cancers patient

BACKGROUND: Breast cancer is a highly heterogeneous pathology, exhibiting a number of subtypes commonly associated with a poor outcome. Due to their high stability, microRNAs are often regarded as non-invasive cancer biomarkers, having an expression pattern specific for their ‘cell of origin’. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braicu, Cornelia, Raduly, Lajos, Morar-Bolba, Gabriela, Cojocneanu, Roxana, Jurj, Ancuta, Pop, Laura-Ancuta, Pileczki, Valentina, Ciocan, Cristina, Moldovan, Alin, Irimie, Alexandru, Eniu, Alexandru, Achimas-Cadariu, Patriciu, Paradiso, Angelo, Berindan-Neagoe, Ioana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196003/ https://www.ncbi.nlm.nih.gov/pubmed/30342533 http://dx.doi.org/10.1186/s13046-018-0920-2

Ejemplares similares

Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
por: Groza, Iulia-Monica, et al.
Publicado: (2020)

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
por: Braicu, Ovidiu-Leonard, et al.
Publicado: (2017)

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors
por: Pop, Laura A, et al.
Publicado: (2016)

p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways
por: BRAICU, OVIDIU, et al.
Publicado: (2015)

Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology
por: Braicu, Cornelia, et al.
Publicado: (2016)

Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death
por: Chira, Sergiu, et al.
Publicado: (2018)

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression
por: Braicu, Cornelia, et al.
Publicado: (2019)

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
por: Ciocan-Cartita, Cristina Alexandra, et al.
Publicado: (2020)

Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells
por: Ciocan-Cartita, Cristina Alexandra, et al.
Publicado: (2020)

Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model
por: Braicu, Cornelia, et al.
Publicado: (2015)

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines—Possible Implications in New Therapeutic Strategies
por: Budisan, Liviuta, et al.
Publicado: (2019)

Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients
por: Cojocneanu, Roxana, et al.
Publicado: (2020)

Next generation sequencing applications for breast cancer research
por: PETRIC, ROXANA COJOCNEANU, et al.
Publicado: (2015)

Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2021)

Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer
por: Jurj, Ancuta, et al.
Publicado: (2023)

miR‐181a/b therapy in lung cancer: reality or myth?
por: Braicu, Cornelia, et al.
Publicado: (2019)

Clinical and pathological implications of miRNA in bladder cancer
por: Braicu, Cornelia, et al.
Publicado: (2015)

Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
por: Achimas-Cadariu, Patriciu, et al.
Publicado: (2022)

The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”
por: Ciocan-Cartita, Cristina Alexandra, et al.
Publicado: (2019)

Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer
por: Zanoaga, Oana, et al.
Publicado: (2018)

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
por: Gulei, Diana, et al.
Publicado: (2018)

A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells
por: Jurj, Ancuta, et al.
Publicado: (2020)

Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health
por: Braicu, Cornelia, et al.
Publicado: (2016)

Progress in Research on the Role of Flavonoids in Lung Cancer
por: Zanoaga, Oana, et al.
Publicado: (2019)

Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines
por: Pruteanu, Lavinia-Lorena, et al.
Publicado: (2022)

The new era of nanotechnology, an alternative to change cancer treatment
por: Jurj, Ancuta, et al.
Publicado: (2017)

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
por: Jurj, Ancuta, et al.
Publicado: (2022)

Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer
por: Saftencu, Mihai, et al.
Publicado: (2019)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells
por: Obasi, Titus Chukwuemeka, et al.
Publicado: (2018)

Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
por: Pileczki, Valentina, et al.
Publicado: (2016)

Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene
por: Cenariu, Diana, et al.
Publicado: (2021)

Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa
por: Jurj, Maria-Ancuta, et al.
Publicado: (2020)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

Identification of a miRNA Panel with a Potential Determinant Role in Patients Suffering from Periodontitis
por: Baru, Oana, et al.
Publicado: (2023)

TP53 gene implications in prostate cancer evolution: potential role in tumor classification
por: Schitcu, Vlad Horia, et al.
Publicado: (2023)

Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis
por: Dudea-Simon, Marina, et al.
Publicado: (2020)

Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2012)

Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
por: Cojocneanu Petric, Roxana, et al.
Publicado: (2015)

Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
por: Irimie, Alexandra Iulia, et al.
Publicado: (2017)

MicroRNA Dysregulation in Prostate Cancer
por: Schitcu, Vlad Horia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q0nebntv5f2s32b7m1qh8sls7l